Noninvasive pulse wave velocity measurement: technological progress, clinical validation, and translation challenges

Pulse wave velocity (PWV) is increasingly recognized as a vital noninvasive metric for assessing arterial stiffness and an established independent predictor of cardiovascular risk. Despite its well-recognized clinical value, the accurate and reliable measurement of PWV remains methodologically challenging due to inherent physical ambiguities, technological heterogeneity across devices, and a lack of comparability between measurements obtained by different systems. This review provides a comprehensive synthesis of the physical foundations, mainstream detection technologies, signal-processing pipelines, and current clinical standardization status for PWV assessment. Although classical frameworks such as the Moens-Korteweg and Bramwell-Hill equations theoretically link PWV to the mechanical properties of the arterial wall, the intrinsic dependence of PWV on instantaneous blood pressure complicates the precise evaluation of structural arterial stiffness in clinical settings. We categorize existing measurement modalities into four principal types: mechanical-pressure sensing, optical techniques, advanced medical imaging, and emerging contactless approaches, each demonstrating unique trade-offs among measurement fidelity, clinical applicability, and operational convenience. Presently, three major barriers hinder the clinical translation of novel technologies: insufficient operational automation, inadequate cross-population validation, and a scarcity of longitudinal prognostic evidence. Future transformative advancements will likely rely on AI-driven, fully automated continuous monitoring systems optimized for real-world daily settings, large-scale multicenter trials across diverse demographics, and extensive long-term cohort studies utilizing wearable devices. These developments will collectively extend PWV assessment from intermittent clinical evaluation toward decentralized, personalized cardiovascular risk management.

Authors

Institutions

Publication Details

Journal
Physiological Measurement
Published
2026-11-13
DOI
https://doi.org/10.1088/1361-6579/aec218
Primary Topic
Cardiovascular Health and Disease Prevention
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Noninvasive pulse wave velocity measurement: technological progress, clinical validation, and translation challenges

Lufei Han, Jiuai Sun, Zhonghang Wu, Mingji Zhang et al.
Physiological Measurement
Cardiovascular Health and Disease Prevention
article

Noninvasive pulse wave velocity measurement: technological progress, clinical validation, and translation challenges

Lufei Han, Jiuai Sun, Zhonghang Wu, Mingji Zhang, Mengying Zheng
article en

Abstract

Pulse wave velocity (PWV) is increasingly recognized as a vital noninvasive metric for assessing arterial stiffness and an established independent predictor of cardiovascular risk. Despite its well-recognized clinical value, the accurate and reliable measurement of PWV remains methodologically challenging due to inherent physical ambiguities, technological heterogeneity across devices, and a lack of comparability between measurements obtained by different systems. This review provides a comprehensive synthesis of the physical foundations, mainstream detection technologies, signal-processing pipelines, and current clinical standardization status for PWV assessment. Although classical frameworks such as the Moens-Korteweg and Bramwell-Hill equations theoretically link PWV to the mechanical properties of the arterial wall, the intrinsic dependence of PWV on instantaneous blood pressure complicates the precise evaluation of structural arterial stiffness in clinical settings. We categorize existing measurement modalities into four principal types: mechanical-pressure sensing, optical techniques, advanced medical imaging, and emerging contactless approaches, each demonstrating unique trade-offs among measurement fidelity, clinical applicability, and operational convenience. Presently, three major barriers hinder the clinical translation of novel technologies: insufficient operational automation, inadequate cross-population validation, and a scarcity of longitudinal prognostic evidence. Future transformative advancements will likely rely on AI-driven, fully automated continuous monitoring systems optimized for real-world daily settings, large-scale multicenter trials across diverse demographics, and extensive long-term cohort studies utilizing wearable devices. These developments will collectively extend PWV assessment from intermittent clinical evaluation toward decentralized, personalized cardiovascular risk management.

Physiological Measurement
Shanghai University of Engineering Science (CN), Jiading District Central Hospital (CN), Shanghai University of Medicine and Health Sciences (CN)
Shanghai Key Laboratory of Molecular Imaging
Good health and well-being
Cardiovascular Health and Disease Prevention
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon